Maxim Group Reiterates Buy Rating on VolitionRX (VNRX) on Fosun Long March MOU
Tweet Send to a Friend
Maxim Group analyst Jason McCarthy reiterated a Buy rating and $6.00 price target on VolitionRX (NYSE: VNRX) announced signing of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
